HealthStream (NASDAQ:HSTM) Price Target Increased to $34.00 by Analysts at Barclays

HealthStream (NASDAQ:HSTM) had its price objective upped by Barclays from $32.00 to $34.00 in a research report released on Wednesday morning, Benzinga reports. Barclays currently has an overweight rating on the technology company’s stock.

Other analysts have also recently issued research reports about the company. Canaccord Genuity Group raised their target price on HealthStream from $27.00 to $28.00 and gave the stock a “hold” rating in a research report on Wednesday, July 24th. StockNews.com cut HealthStream from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 24th. Finally, Craig Hallum raised HealthStream to a “strong-buy” rating in a research report on Thursday, October 17th. Two investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $31.50.

HealthStream Stock Down 4.8 %

HSTM opened at $28.63 on Wednesday. The firm has a market cap of $870.29 million, a PE ratio of 49.36, a P/E/G ratio of 4.25 and a beta of 0.36. The business has a fifty day simple moving average of $28.70 and a 200-day simple moving average of $27.88. HealthStream has a fifty-two week low of $22.84 and a fifty-two week high of $31.15.

HealthStream (NASDAQ:HSTM) last released its quarterly earnings data on Monday, October 21st. The technology company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.06. The business had revenue of $73.10 million during the quarter, compared to analyst estimates of $73.53 million. HealthStream had a return on equity of 5.19% and a net margin of 6.26%. The company’s revenue was up 4.0% compared to the same quarter last year. During the same period last year, the company posted $0.13 EPS. On average, equities research analysts anticipate that HealthStream will post 0.56 EPS for the current fiscal year.

HealthStream Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Monday, November 4th will be issued a dividend of $0.028 per share. The ex-dividend date is Monday, November 4th. This represents a $0.11 annualized dividend and a dividend yield of 0.39%. HealthStream’s dividend payout ratio is 18.97%.

Insider Buying and Selling

In related news, Director Tate Deborah Taylor sold 1,400 shares of the stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $28.53, for a total transaction of $39,942.00. Following the completion of the sale, the director now directly owns 22,326 shares in the company, valued at approximately $636,960.78. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other HealthStream news, Director Tate Deborah Taylor sold 1,400 shares of the firm’s stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $28.53, for a total transaction of $39,942.00. Following the transaction, the director now directly owns 22,326 shares in the company, valued at $636,960.78. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Kevin P. O’hara sold 3,000 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $28.03, for a total value of $84,090.00. Following the transaction, the senior vice president now owns 9,527 shares in the company, valued at approximately $267,041.81. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 20.60% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On HealthStream

Hedge funds and other institutional investors have recently made changes to their positions in the business. Wakefield Asset Management LLLP acquired a new stake in shares of HealthStream in the first quarter valued at about $909,000. Vanguard Group Inc. grew its position in shares of HealthStream by 1.1% in the first quarter. Vanguard Group Inc. now owns 2,938,685 shares of the technology company’s stock valued at $78,345,000 after purchasing an additional 31,943 shares during the last quarter. State Board of Administration of Florida Retirement System grew its position in shares of HealthStream by 1.5% in the first quarter. State Board of Administration of Florida Retirement System now owns 78,749 shares of the technology company’s stock valued at $2,134,000 after purchasing an additional 1,131 shares during the last quarter. Deerfield Management Company L.P. Series C acquired a new stake in shares of HealthStream in the second quarter valued at about $626,000. Finally, Assenagon Asset Management S.A. grew its position in shares of HealthStream by 58.6% in the second quarter. Assenagon Asset Management S.A. now owns 146,826 shares of the technology company’s stock valued at $4,096,000 after purchasing an additional 54,227 shares during the last quarter. 69.58% of the stock is owned by institutional investors and hedge funds.

About HealthStream

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.